Toda, Japan

Shuntarou Kohnomi

This inventor holds 1 USPTO granted patent. Top assignee: Mitsubishi Tanabe Pharma Corporation. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shuntarou Kohnomi. Retrieved from https://idiyas.com/inventor/shuntarou-kohnomi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Shuntarou Kohnomi

Introduction

Shuntarou Kohnomi, an inventive mind hailing from Toda, Japan, has made a significant impact in the field of pharmaceuticals. With a focus on advancing medical science, Kohnomi has secured a prominent patent that demonstrates his dedication to innovation.

Latest Patents

Kohnomi holds a patent for a "Large conductance calcium-activated K channel opener." This invention includes a compound of the formula (I), which plays a crucial role in enhancing the functionality of calcium-activated potassium channels. This advancement has substantial implications for various medical treatments.

Career Highlights

As part of Mitsubishi Tanabe Pharma Corporation, Kohnomi has been at the forefront of research and development. His career in this reputable company underscores a commitment to excellence in the pursuit of new therapeutic options.

Collaborations

Throughout his career, Kohnomi has collaborated with notable professionals, including Toshihiro Hosaka and Mari Kusama. These partnerships signify the importance of teamwork in driving innovation in the pharmaceutical field.

Conclusion

Shuntarou Kohnomi's contributions to modern medicine through his inventive spirit and collaborative efforts are commendable. As he continues to work at Mitsubishi Tanabe Pharma Corporation, the potential for future innovations remains promising, further reflecting his dedication to the advancement of healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…